Thus, in a selected population of high-risk men with oligorecurrent PCa, the PSMA-PET directed approach may represent a promising second-line salvage approach to delay the further progression to polimetastatic and CRPC status. The gene discussed is FOLH1; the disease is posterior cortical atrophy.